WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 8, 2006--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI - News) today reported financial results for the second quarter and first six months of 2006. The Company recorded total revenue of $4.6 million in the second quarter of 2006 and $15.5 million in the first half of 2006. This compares to $4.2 million in the second quarter of 2005 and $8.2 million in the first half of 2005.
